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Mass spectrometry-based metabolomics approaches can enable detection and 80 
quantification of tens to 10,000’s of metabolite features simultaneously. 81 
However, compound identification and reliable quantification is greatly 82 
complicated due to the chemical complexity and dynamic range of the 83 
metabolome. Simultaneous quantification of many metabolites within complex 84 
mixtures can additionally be complicated by ion suppression, fragmentation, 85 
and the presence of isomers. As a result, in the absence of necessary controls, 86 
misinterpretation of metabolomics data can easily occur. Here, we present 87 
guidelines to ensure reliable peak annotation and more robust quantification as 88 
a means to enable high quality reporting of mass spectral metabolomics- 89 





Metabolomics, the large-scale study of the metabolic complement of the cell 1-3 , is now 95 
a mature science which has been practiced for over 20 years 4, 5. Indeed, it is now a 96 
commonly-used experimental systems biology tool with demonstrated utility in both 97 
fundamental and applied aspects of plant, microbe and mammalian research6-19. 98 
Among the many thousands of studies published in this area over the last twenty years 99 
notable highlights 6-12 are  briefly described in Supplementary Note 1. 100 
Despite the insight afforded by such studies, the nature of metabolites particularly their 101 
diversity (both in chemical structure and dynamic range of abundance13, 14) remains a 102 
major challenge with regard to our ability to provide adequate coverage of the 103 
metabolome that can complement the genome, transcriptome and proteome. Despite 104 
these comparative limitations enormous advances have been made with regard to the 105 
number of analytes we can acquire accurate quantitative information and a vast 106 
number of studies have yielded important biological information and biologically active 107 
metabolites across the kingdoms of life 15. We have previously estimated that upwards 108 
of 1 million different metabolites occur across the tree of life with between 1000 and 109 
40 000 being estimated to occur in a single species 5. However, to date, even the most 110 
comprehensive methods are not able to approach comprehensitivity. The above-111 
mentioned features of chemical diversity and broad dynamic range in cellular 112 
abundance currently prohibit the possibility of extracting and measuring all metabolites 113 
using single extraction and analytical procedures16, 17. Consequently, many different 114 
extraction techniques and combinations of analytical methods have been developed 115 
in an attempt to achieve adequate metabolite coverage. This renders the 116 
establishment of good working practices 18-23, more difficult than those associated with 117 
RNAseq 24-27 24. Furthermore, rigorous standards are needed for normalization of 118 
metabolomics data 28, 29. This is exacerbated by the breadth of aims associated with 119 
the measurement of metabolites which encompasses; targeted metabolite analysis, 120 
metabolite profiling, flux profiling, metabolomics-scale analysis and metabolite 121 
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fingerprinting techniques 4, 30-32. Given the myriad of aims and methodologies, as well 122 
as the rapid turnover times of metabolites, we argue it is particularly important to define 123 
clear guidelines for acquisition and reporting of metabolite data since there are many 124 
potential sources of misinterpretation. This is of course not the first time such 125 
guidelines have been suggested with several insightful papers published on this topic  126 
14, 33 34 and a considerable number of long established metabolome databases 127 
including MetaboLights35,36-38 and the Metabolome Workbench 128 
(https://www.metabolomicsworkbench.org/) also driving this field. A more detailed 129 
description of these guidelines and repositories as well as of more recent 130 
developments is provided in Supplementary Note 2. Although the detailed standards 131 
sets out by the metabolomics standards initiative and these repositories are laudable 132 
and clearly represent the gold-standard of metabolomics reporting it is notable that the 133 
number of published metabolomics studies both far exceeds the number following 134 
these in their entirety and those submitting their data to the metabolome databases. 135 
There are probably several reasons underlying this. First, few journals currently 136 
mandate that data is stored in one of the metabolomics repositories. Secondly, unlike 137 
the situation 20 years ago, or even when the work of the metabolomics initiative was 138 
first published some 13 years ago 33 39-41, metabolomics experiments are often a 139 
component, rather than the entire study. Aligned to this fact is that many groups 140 
outsource their metabolomics workflow to companies or similar service providers and 141 
do not always have either the experience to provide, or even full access to the raw 142 
data. In parallel requiring reviewers to comment on all aspects of multi-omics in the 143 
absence of clear guidelines regarding what may not be their key area of competence 144 
is a big ask. Finally, and perhaps most tellingly is the difficulty in reporting 145 
chromatogram level information with several weeks and often several attempts 146 
required to fulfil the criteria of the major metabolomics repositories 147 
 148 
Our aim here is to present a simplified reporting workflow with the hope of capturing 149 
more of the missing information. By contrast to the suggestions of the metabolomics 150 
standards initiative 33 39-41 and the major repositories mentioned above we propose to 151 
perform this at the level of the processed data (supported by the provision of 152 
representative chromatograms allowing the assessment of metabolite identifications), 153 
rather than the raw chromatograms. A similar suggestion was made to the Plant 154 
research community in 201142. However, it is notable that of the 172 citations accrued 155 
by this publication as of September 2020 153 were related to plants). We have 156 
therefore in the following rewritten and updated these suggestions to (i) be more 157 
globally applicable and (ii) to reinforce our contention that quantitation control 158 
experiments should be regarded as mandatory and can aid in determining how 159 
problematic the effects of ion suppression are in an experiment. To this end we 160 
highlight potential sources of error and provide recommendations for ensuring the 161 
robustness of the metabolite data obtained and reported. Our article will include clear 162 
guidelines for sampling, extraction and storage, metabolite identification and reporting. 163 
It will stress the need for recombination and recovery experiments aimed at checking 164 
both qualitative metabolite identifications and their quantitative recovery. In addition, it 165 
will provide a suggestion for a stricter nomenclature for metabolite annotations which 166 
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would improve reporting by removing much of the ambiguity concerning the quality of 167 
metabolite annotation that is currently apparent in many metabolomics studies. Indeed 168 
this article aims at covering all aspects of reporting from sample extraction through to 169 
data evaluation but will not detail downstream computational evaluation of the 170 
acquired datasets despite there being several important advances in this regard 43, 44 171 
45 46, 47 48 49. These tools and their application are outlined in Supplementary Note 3. 172 
Such efforts are necessary to allow the inter-laboratory comparisons of datasets 173 
which, as has been demonstrated for transciptomics, provides huge statistical power 174 
and deeper biological insights as well as opening a route for better integration with 175 
other datasets 50-52. Whilst nuclear magnetic resonance (NMR) and capillary 176 
electrophoresis mass spectrometry (CE-MS) both have their advocates and have clear 177 
advantages in structure elucidation and sensitivity, respectively, given that the majority 178 
of metabolomics studies rely on the complementary techniques of chromatography 179 
hypenated with mass spectrometry (MS, either gas chromatography (GC) or liquid 180 
chromatography (LC) respectively) we will therefore focus this paper on such 181 
techniques.   182 
 183 
As mentioned above, metabolites exhibit tremendous chemical diversity, thus differing 184 
from nucleic acids and proteins which are constructed via genetically encoded 185 
polymerization of a small number or building blocks 3, 53, 54. Alongside their dynamic 186 
range in concentration and half-life this chemical complexity presents a range of 187 
challenges when attempting comprehensive profiling of the cellular small molecule 188 
complement. These difficulties are sufficient that no single analytical technique, let 189 
alone no single protocol can capture all metabolites. Taken together with our 190 
incomplete understanding of the spontaneous chemical reactions of the cell 55, this 191 
means that we cannot even be certain as to what constitutes the full metabolite 192 
complement of a given system. That said, our current capabilities for detection and 193 
quantification of metabolites fall a long way short of being comprehensive. To illustrate 194 
this point, currently combinations of the most comprehensive methods are able to 195 
quantify 700 of the 3700 metabolites predicted to be present in E.coli 56, 57, 500 of the 196 
2680 metabolites predicted to be present in yeast 58, 59, 8000 of the 114100 metabolites 197 
predicted to be present in in human 60 and only 14000 of the over 400000 metabolites 198 
predicted to be present in the plant kingdom 5, 61, 62. The pursuit of ever-greater 199 
coverage of the metabolome is likely to remain the grand challenge of metabolomics 200 
for some time. However, there are nonetheless a number of other important topics that 201 
should considered. Amongst these critical issues is how to ensure deep coverage 202 
while retaining high data quality and annotation confidence. 203 
 204 
Sampling, quenching, metabolite extraction and storage  205 
The very first (and particularly vital) step in the metabolomics workflow (Figure 1 and 206 
2) is the rapid stopping or quenching metabolism and extracting the metabolites in a 207 
manner which produces a stable extract which is quantitatively reflective of the 208 
endogenous metabolite levels present in the original living cell. This is especially 209 
important in highly metabolically active systems such as cells and tissues but less so 210 
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in biofluids such as serum plasma or urine samples 14. Indeed, there is no one method 211 
to fit all cases, with specific sampling, quenching, and extraction needed for each 212 
tissue type. That said the certain evaluations of quality are universally applicable and 213 
our aim here is to provide clear instructions on how to apply them. Quenching needs 214 
to satisfy two criteria: (i) it needs to completely terminate all enzyme and chemical 215 
activities and (ii) it needs to avoid the perturbation of existing metabolite levels during 216 
harvesting. Details regarding specific considerations that need to be taken into 217 
account for quenching the metabolism of various species are provided in 218 
Supplementary Note 4. The efficiency of quenching can be followed either by 219 
controlled comparisons of various extraction methods33 or alternatively by determining 220 
the abundance of (stable-isotope labelled) standards spiked into the quenching 221 
solvent (see recovery and recombination experiments). For tissues, where possible, 222 
quick excision and snap-freezing in liquid nitrogen is recommended with subsequent 223 
storage of deep-frozen tissue at constant -80 °C until the first application of extraction 224 
solvent. However, for bulky tissue, submersion in liquid nitrogen is not sufficient since 225 
the center of the tissue is cooled too slowly. In such cases freeze-clamping - where 226 
tissue is almost instantaneously squashed flat between two pre-frozen metal blocks 227 
(known as a Wohlehberger clamp) is preferred 42, 63, 64. Irrespective of the quenching 228 
method, downstream steps of these processes also warrant caution. For example, 229 
improper freeze drying and lack of storage in sealed containers can generate 230 
artifactual geometric isomers of pigments 42. Freeze drying is also unsuitable when 231 
volatile components are of interest. Whilst the appropriate means of storage is strictly 232 
dependent on the stability of the class of targeted metabolites under study, it is not 233 
recommended to store samples between 0 and 40 °C. At these temperatures, 234 
substances can become concentrated in a residual aqueous phase 42. It is therefore, 235 
recommended, where necessary, to store completely dry residues for as short a time 236 
as possible before their analysis. In addition, great care must be taken to ensure that 237 
metabolism remains quenched during thawing. This is particularly pertinent for 238 
extracts containing secondary metabolites where degradative enzymes often retain 239 
their activities which, if not kept in check, may result in the consumption or conversion 240 
of certain metabolites with a concomitant appearance of new compounds or 241 
breakdown products 65. Similar issues are apparent with respect to both experimental 242 
growth media and the initial extraction solvents used. Growth media often needing to 243 
be removed via multiple wash steps in order to reduce the effects of ion suppression 244 
during the subsequent MS analysis, and the solvent used for initial extraction may 245 
need to be exchanged due to incompatibility with the instrumentation used for the 246 
metabolite analysis per se. Two pitfalls are apparent here; (i) loss of metabolites in the 247 
washing process and (ii) solvent removal leads to concentration of the metabolites and 248 
thereby an acceleration of chemical reactions occurring between them. Thus, 249 
considerable caution is advised in method optimization to ensure that extraction and 250 
handling methods allow adequate quantitative representation of cellular metabolites. 251 
In some instances, such as the analysis of volatile or semi-volatile compounds, sample 252 
extraction and handling should only be performed on fresh material. In either case, we 253 
recommend that the adoption of recovery and recombination experiments (see 254 
Recovery and recombination experiments) be mandated either when a substantially 255 
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novel metabolomics technique is introduced or when a novel cell type, tissue or 256 
organism is studied. 257 
 258 
Sample replication and randomization 259 
The nature and number of biological, technical and analytic replicates is a further issue 260 
worthy of consideration. Before employing any new extraction protocol or analytical 261 
procedure and when working with new biological materials it is essential to perform 262 
extensive pilot experiments in order to assess fully the technical variation which is 263 
necessary to design a statistically sound experiment. To avoid misunderstanding, we 264 
refer readers to the definitions of each type of replicate provided in 42. While analytical 265 
replicates, i.e. the repeated injection of the exact same extract, are useful in assessing 266 
machine performance, technical replicates which encompass the entire experimental 267 
procedure allow a far more comprehensive  assessment of any experimental variance 268 
in data generation 42. Indeed, such analyses are essential for the establishment of a 269 
new extraction or processing procedure, a new analytic technique or the optimization 270 
of a new instrument. Beyond these cases, biological replication is considerably more 271 
important and should involve at least four but preferably more replicates, although the 272 
required number of replicates depends on the desired statistical power, effect size and 273 
actual variances66. Care must be taken to harvest such replicates in a highly uniform 274 
manner. For plants, this can also mean harvesting at the same time of day and under 275 
the same environmental conditions. In many instances, a full and independent repeat 276 
of a biological experiment is advisable67. There are different stages where technical 277 
replicates can be made; at the sampling, the quenching, the extraction and the 278 
analysis independently the entire process. From experience the extraction step is the 279 
most critical of these. Whether technical replication is needed in support of biological 280 
replication is highly dependent on their relative magnitudes in cases in which the 281 
biological variation greatly exceeds technical variation it is sensible to sacrifice the 282 
latter to increase the former. Pilot experiments with new systems are highly 283 
recommended to evaluate biological and technical variation and hence determine how 284 
many samples and how many replicates are needed for final statistical robustness66 285 
 286 
Careful spatiotemporal randomization of biological samples throughout workflows is 287 
equally essential. If a set of samples is analyzed in a non-random order, treatment and 288 
control samples or time-points may end up getting measured under very different 289 
conditions, and as a result interpretation can be confounded by sample age or shifting 290 
instrument performance, potentially occluding biological variation between sample 291 
groups, or worse, creating artefactual differences. This is particularly important in 292 
large-scale metabolic profiling that characterizes studies of natural variation of 293 
metabolism such as genome wide association studies 10, 68-71. Here, even weeks of 294 
instrument time may be required. Clear best practice guidelines for such large-scale 295 
studies have been presented elsewhere 72-76, so we will not dwell on them here. 296 
Irrespective of the size of the experiment, the use of quality control samples and batch 297 
correction are also essential 77. Such experimental controls help monitor instrument 298 
performance and stability and thereby data quality. These controls ensure that missing 299 
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data or peaks with low signal to noise ratios occur. Either mixtures of authentic 300 
metabolite samples at defined concentrations or dry-stored aliquots of a broadly-301 
shared and appropriately standardized biological extract (for example multi kilogram 302 
extracts of Arabidopsis, E. coli, yeast or human cell lines) could likely serve as broadly 303 
useful reference samples. This would likely enhance accurate quantifications and 304 
render rendering the utility of metabolite databases more effective 78-82. Pooled QC 305 
sample allows for evaluation (and correction) of run-order and batch effects within a 306 




The aforementioned details of extraction, storage and replication are equally 311 
applicable for ensuring the accuracy of any method of metabolite quantification, 312 
including those that target single metabolites (Figure 2). The remainder of this article 313 
will address issues that are, at least partially, restricted to untargeted metabolomics 314 
approaches. There are several essential aspects that need consideration here. First, 315 
it is essential to ensure that the levels of all metabolites of potentially interest can be 316 
detected and ideally, can be measured within linear range of detection. This is most 317 
readily achieved through the analyses of independent dilutions of each extract. 318 
Additionally, for experiments that begin with intact tissues it is important to ensure 319 
complete tissue disruption. In the case of cellular studies one must further take into 320 
consideration whether to limit the study to the endogenous cellular metabolites or 321 
whether to also assess the exo-metabolome. For these controls, and many others, we 322 
provide a list of reporting recommendations in the section on transparency in 323 
measurement, metabolite annotation and documentation below. Most frequently 324 
metabolomics data are provided as relative quantities (i.e. relative quantification is 325 
performed) with respect to a reference sample. This is in contrast to NMR based 326 
studies which usually provide absolute concentrations (i.e. absolute quantification) 327 
with peak intensities are directly proportional to concentrations and directly 328 
comparable across different peaks and samples. In contrast, the relative intensities of 329 
LC-MS and GC-MS peaks representing different compounds do not directly correlate 330 
to their absolute concentrations. This is due to the differential ionization efficiencies of 331 
the different metabolites within a complex mixture. To address this issue, standard 332 
curves can be used to determine how signal intensity responds as a function of analyte 333 
concentrations and moreover the range of linearity of this relationship14. This is of 334 
course dependent on the availability of validated pure standards. Whilst relative values 335 
are highly useful in many contexts and indeed are the only way of expressing the levels 336 
and changes of non-annotated analytes, absolute values have much greater utility 337 
being able to determine enzyme binding site occupancies, the thermodynamics of 338 
metabolic reactions14, 83, and the molecular dynamics underlying the flow of atoms 339 
through a metabolic network 84-88. A further advantage of the methods used for 340 
absolute quantification is that they can be readily adapted into a means of quality 341 
control for both quantification and the correctness of peak annotation e.g. through 342 
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thermodynamics89. However, obtaining standard curves for many thousand 343 
metabolites in a complex mixture is currently not always practical. 344 
 345 
Recovery and recombination experiments 346 
Recovery experiments in which authentic standard compounds are added to the initial 347 
extraction solvent in order to assess losses during extraction, storage and handling 348 
were vigorously championed in the 70s-90s 90, 91  and can provide persuasive evidence 349 
that the data reported provide a valid reflection of cellular metabolite compositions 42. 350 
Recent examples have been provided that validate methods in microbial, plant and 351 
mammalian systems 92-94. However, the metabolomics community has been relatively 352 
slow in adopting these control procedures. This is partially explained by the lack of 353 
commercially available and/or simple to synthesize standards. Indeed, this is de facto 354 
the case for unknown analytes for which this approach is impossible. Fortunately, 355 
there is an alternative approach – that of extract recombination – which circumvents 356 
this practical limitation. In this approach the extract of a novel tissue is characterized 357 
by combination with that of a well characterized reference material such as one from 358 
E. coli, A. thaliana or human biofluids. Such experiments not only provide information 359 
concerning the appropriateness of the extraction buffer but additionally allow an 360 
assessment of so-called matrix effects caused by ion suppression 95-97. These 361 
experiments additionally allow a quantitative assessment of the reliability of known 362 
peaks98. A schematic representation of recovery and metabolic recombination 363 
experiments is presented in Figure 3. We suggest that for known metabolites, recovery 364 
or metabolic recombination experiments are carried out for each new tissue or species 365 
type. It is clear that for any metabolomics-scale study certain metabolites will have 366 
poor recoveries. While this does not preclude the reporting of their values it is 367 
important that this is documented in order to allow the readers discretion in their 368 
interpretation. Recoveries of 70-130% are acceptable with anything deviating beyond 369 
this range representing a metabolite whose quantification should be subject to further 370 
testing. For example even a 50 % recovery - if reproducible and linear - could be 371 
deemed acceptable (Figure 3). The importance of such control experiments is perhaps 372 
best illustrated with cases in which they were not carried out. Anecdotally, there are 373 
several examples in the literature wherein the metabolite data reported cannot be 374 
reflective of their cellular content; e.g. since for example zero levels have even been 375 
reported for metabolites which, if representative of cellular levels, would indicate that 376 
the cells tested were inviable.  377 
 378 
A further aspect of quantitation is the basis on which this is expressed for tissue 379 
samples data is often provided per gram fresh or dry weight, whilst for body fluids this 380 
is often provide per volume. The case of cell metabolomics is more complicated given 381 
that cell size is often variable values are therefore often provided per mg protein, or 382 
based on cell counts. The basis on which both absolute and relative metabolite levels 383 
is provided is of fundamental importance - for example values on a fresh weight basis 384 
can be dramatically influenced by the osmotic potential of the cell -yet is often not 385 
given enough consideration by the community. 386 
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Ion suppression 387 
Despite the selectivity and sensitivity of mass spectrometry techniques, there are 388 
considerable challenges with regard to reproducibility and accuracy when analyzing 389 
complex samples. These problems are not insurmountable but require that extra care 390 
is taken when interpreting results. Ion suppression is a general problem in LC–MS 391 
analyses due to matrix effects influencing the ionization of coeluting analytes, affecting 392 
precision and accuracy of their quantification, or preventing less abundant metabolites 393 
from getting detected at all 95, 97, 99. As mentioned above the best method of assessing 394 
it is in the mixture of two independent extracts in a recombination experiment (see 395 
Figure 3) and subsequent assessment as to whether the metabolites detected can be 396 
quantitatively recovered100. Essentially, within this process co-eluting analytes 397 
compete for the ionization energy, resulting in incomplete ionization. Therefore, 398 
observation a decreased ion count for an analyte may be due either to decreased 399 
concentration of the analyte itself or increased concentrations of co-eluting analytes. 400 
It is critically important to consider these effects during method validation to ensure 401 
the quality of the analysis. While there is no universal solution to the ion suppression 402 
problem, assessing the effects of ion suppression affords greater confidence in the 403 
accuracy of the results. However, there are several strategies that can help minimize 404 
ion suppression96. Among these improving sample preparation and chromatographic 405 
selectivity are currently the most effective ways. In some situations, using suitable 406 
cleanup procedures depending on sample type and analyte properties may allow to 407 
remove co-eluting components. This might involve simple dilution of extracts 65 or of 408 
the growth media the samples are derived from65 or optimization of various steps of 409 
sample workup, including sonication, solvent partitioning, filtration, centrifugation, and 410 
protein precipitation101. In addition, solid phase extraction (SPE) using appropriate 411 
absorbents has been demonstrated as an effective method to reduce matrix effects. 412 
Furthermore, it is possible to adjust chromatography conditions so that peaks of 413 
interest are not eluting in regions of suppression, for example, modifying mobile phase 414 
composition or gradient conditions can aid chromatographic separation and thereby 415 
improve performance. Careful selection of the ion source and column polarity is an 416 
alternative strategy to reduce ion suppression, for example, APCI is less to matrix 417 
effects compared to ESI. In addition, using APCI can also reduce interference effects 418 
14. It has been demonstrated that ion suppression is often less severe for negatively 419 
ionized compounds than for positively charged ones102 . Finally, even though the 420 
above-mentioned strategies may not suffice to completely remove the effects of ion 421 
suppression in complex samples, the extent of the problem can at least be quantified 422 
via the carrying out control experiments as described in the Recovery and 423 








Peak misidentification 430 
The orthogonal use of chromatography (either gas or liquid based) with mass  431 
spectrometry and in some cases also MS/MS fragmentation patterns provides great 432 
specificity 103 104. Indeed current high-end instruments detect on the order of 10,000 or 433 
100,000 features, however, these include a large number of adduct and isotope peaks. 434 
Bioinformatics tools for analyte identification take this into account and even use 435 
commonly observed adducts as a means of identifying analytes (discussed in detail 436 
below). Nonetheless, there are three common problems that contribute to mis-437 
identification – the third of which being relevant more for LC- than GC-MS. Firstly, 438 
isomers – compounds with identical molecular formula but distinct structures – are 439 
common in nature. Important examples from primary metabolism include hexose-440 
phosphates/inositol phosphates, citrate/isocitrate, glucose/fructose and 441 
alanine/sarcosine. High-resolution MS alone may not suffice to discriminate between 442 
these and other sets of isomers, especially when fragmentation patterns are similar, 443 
and some types of isomers may not separate well on conventional reverse-phase 444 
HPLC. To improve separation, reversed-phase ion pairing chromatography, HILIC, 445 
and other chromatographic methods can be used14; another option is chemical 446 
derivatization prior to chromatography 14. In cases where isomers cannot be separated 447 
this needs to be clearly stated since they may display highly different biological 448 
functions. Secondly, the presence of overlapping compounds may prevent detection 449 
of some metabolites. Whilst the increasingly high resolution of mass spectrometers 450 
has mitigates this issue to some extent, the resolving power of many current 451 
instruments is insufficient to separate ions differing in mass by less than 5 ppm14. This 452 
problem, however, is only acute when chromatography is also unable to separate 453 
analytes that cannot be separated on the basis of their masses. The third major hurdle 454 
is that of in-source degradation products these are byproduct ions of electrospray 455 
ionization owing to simple loss of water, carbon dioxide of hydrogen phosphate, more 456 
complicated molecular rearrangements, and the attachments of other ions. In-source 457 
degradation reduces the intensity of the metabolite parent ion and the resulting 458 
fragment ions may confound analysis of other co-eluting compounds, e.g. if they have 459 
the same molecular formula as the molecular ion of another metabolite14. We provide 460 
examples of these from our own work in Supplementary Figure 1. This example 461 
demonstrates the need for careful manual curation of all peak assignments, which, 462 
however, is often not feasible when annotating several 100 or 1000 metabolites 463 
(Figure 4). In ambiguous cases, the exact identification of a peak can often be best 464 
demonstrated via comparative biochemical approaches, e.g. by analyzing the 465 
metabolome in known mutants which can be anticipated to lack certain metabolites 22, 466 
105 or the incubation of a purified peak with known enzymes or chemical treatments 93. 467 
This can also be combined with other approaches such as using authentic standards 468 







Transparency in measurement, metabolite annotation/documentation 474 
In order to fully exploit metabolomics data they need to be comparable between 475 
different laboratories. Indeed several comparative studies have been published as we 476 
detail in Supplementary Note 5. In addition to comparability at a quantitative level 477 
clear metabolite ontologies are also needed to ensure that metabolites are annotated 478 
in a common fashion see Supplementary Note 6. Indeed both issues are important 479 
enough to merit a further article related to post data-acquisition of metabolomics data. 480 
Furthermore to ensure that methods can be readily adopted by others, a wealth of 481 
detailed information is required. However, currently this detailed descriptions of 482 
sample preparation and analytical procedures is often (at least partially) absent in 483 
publications, especially in cases where metabolomics is not the primary focus of the 484 
published work. We recommend the following items should be considered as 485 
mandatory components of any methods section for metabolomics experiments.  Mass 486 
spectrometry: ionization source and type of detection mode, MS method, scan number 487 
and speed, MS/MS parameters, including resolution settings and the energy used for 488 
fragmentation (Box1). The description of the chromatography methods must include a 489 
detailed description of the compositions of the mobile phase, column properties, 490 
temperature, flow rate, and injection volume. Extensive recommendations have been 491 
made before 42 39; however, we believe that this list will need to be revisited frequently 492 
due to improvements in instrumentation and other aspects of the metabolomics 493 
workflow. If unsure, imagine that your twin is sitting on a different continent in front of 494 
similar instrumentation, and has to configure the equipment in a comparable manner. 495 
Increasingly, there is software support to extract such information from raw data files 496 
converted into e.g. the mzML file format 49 (see figure 4 C). 497 
Considering the number of possible pitfalls in the correct annotation and quantification 498 
of metabolites in metabolomics approaches the current general level of reporting in 499 
the literature is not entirely satisfactory (Figure 4 and 5). Given restrictive journal word 500 
limits and the fact that scientific reports tend to be highly concise, it is perhaps not 501 
surprising that authors do not refer to compounds as “the metabolite which we 502 
putatively annotate as X’’ within the text of their articles. That said, there is nothing to 503 
preclude highly detailed reporting of the exact nature of the annotation within the 504 
Supplementary Data associated to a paper, either being co-published or made 505 
available through separate web resources. Databases such as MetaboLights65 and 506 
Metabolomics Workbench108 can be used for this purpose, and indeed have been 507 
adopted as a requirement for many journals. We also recommend a streamlined and 508 
hence simpler reporting within the Supplementary Data and Figure 4. Whilst this is 509 
similar to that previously suggested for plant analyses42 we have updated reporting 510 
recommendations to ensure broader applicability and relevance. To simplify the 511 
adoption of these recommendations we supply Supplementary Tables 1 and 2 online 512 
as template Microsoft Excel spreadsheets. Supplementary Table 1 contains a list of 513 
simple questions regarding the reporting of metabolite data whilst Supplementary 514 
Table 2 provides recommendations for supplementary data to be provided on the 515 
presentation of a typical GC- or LC-MS experiments. Once used to filling out such 516 
Tables it is our experience that it takes between 30 and 60 minutes to complete the 517 
process which is at least one, if not two, order(s) of magnitude less time than required 518 
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for fulfilling the requirements of the data repositories. We believe that a more 519 
widespread adoption of these recommendations will enhance the quality of reporting 520 
of metabolite data, advance community efforts to improve the annotation of 521 
metabolomes, and finally to facilitate the exchange and inter-comparability of 522 
metabolite data from different laboratories. These effort will also facilitate comparison 523 
of metabolomics data sets obtained from different species, supporting the renaissance 524 




In summary, we have here presented a range of recommendations to improve quality 529 
and cross-laboratory comparison of metabolic datasets. These range from sampling 530 
and metabolite extraction, quantification, peak misidentification, to transparency in 531 
measurement and documentation for which a data- rather than chromatogram- centric 532 
approach is suggested.We would anticipate that their adoption will offer several 533 
advantages: (i) importantly they will provide the reader with the ability to assess the 534 
quality of the data reported and as such allow greater confidence in the conclusions 535 
drawn; (ii) they will allow researchers a simple route to gain information needed to aid 536 
them in annotating their own experimental output and (iii) they will allow the facile 537 
comparison of data obtained via multiple laboratories. A recent exemplary 538 
documentation of a metabolomics experiment is provided by the study of Price et al 539 
109, who evaluated metabolite levels in under-studied crop species providing an 540 
extensive database of the underlying data. Greater adoption of reporting of this type 541 
either using the simple reporting table here or the similar one proposed by Dorrestein 542 
and co-workers (for a comparison of these Tables please see Supplementary Note 543 
7) have the potential to elucidate general aspects of the metabolic response. For 544 
example simple studies based on data collected as suggested in our earlier plant-545 
based reporting standards were interrogated in order to identify specific and general 546 
metabolic responses to abiotic stress 110. Such studies have been greatly enhanced 547 
via recent the computational approaches of Dorrestein and co-workers 43, 45, 111, which 548 
highlighted the power of combining metabolomics datasets in analyzing the effect of 549 
the microbiome on the human metabolome111 , facilitating the discovery of antiviral 550 
compounds43 and evaluation of likely poisonous metabolites in dart frog skin 45. 551 
Further development of both chromatogram-dependent and chromatogram 552 
independent computational metabolomics will likely aid greatly in such endeavors, it 553 
is, however, beyond the scope of our current article. Expansion of such approaches, 554 
including both experimental and computational scientists, will facilitate the generation 555 
of pan-metabolome databases which will undoubtedly open of new horizons for 556 






Box 1. Information required for transparency in measurement and metabolite annotation/documentation 
Chromatography Ref. 
 Instrument description: manufacturer, model number, software and version. 
 Separation conditions: Column parameters ( model, number, thickness, diameter, length, particle size) 
 Separation method: Mobile-phase composition and modifiers, flow rate, gradient program, column 
temperature, pressure, temperature, injection; split or splitless, injection cycle time    
39, 42 
Mass spectrometry  
 Instrument type and parameters: model, software and version  
 Type of ionization (ESI, EI, APCI, or others), positive or negative polarity. Other ionization parameters 
(voltage, gas, vacuum, temperature). 
 Mass analyzer: (TOF, Orbitrap, ion-trap, FT-ICR, etc.), hybrid or single mass analyser used for the 
experiment. Collision energy used for fragmentation. 
 Instrument performance (resolution, sensitivity, mass accuracy, scan rates) 
 Acquisition mode (full scan, MSMS, SIM, MRM, ddMS, etc.) 
 Detector 
39, 42 
Metabolite documentation (minimum Ontology)  
 Details are represented in figure 4 and supplementary tables 1 and 2. Included minimum proposed 
reporting data:  retention time, theoretical monoisotopic mass, the ion (M-H)- and or (M+H)+, m/z 
detected in the experiment, m/z error (in ppm), MS/MS. fragments, obtained from the ion (M-H)- and/ 
or(M+H)+, metabolite name, compound class. 
 For known compound we proposed to add: international identifiers (such as: HMDB, KEGG, PubChem, 
KNApSAcK, etc.). 
 Quantified data (peak intensity, area, etc.) across the experiment must provide as .xls or .text file as 
supplementary table. 
 Representative chromatogram/s allowing the assessment of metabolite identifications. 
42, 112 
More extensive Ontology*  
 Check requirements for repository submission. 
 Data formats, such as NetCDF for MS data.  
 International metabolite identifiers. 
 Data availability, free available, published or not.   
 Summary about the experiment. 
 Authentic or reference spectral used for identification. 
 Code or other information used for analysis if available.   
 In the case of submission downstream data (results), the minimum structure for table format and 
experiment must be provided, see Hoffmann, et al., 2019 for example. 




*Recommendation in case submitting the raw data or downstream results to repositories databases 561 










Main Figures 570 
Figure 1. Metabolomics workflow 571 
Metabolomics involves several basic steps: including sample preparation and 572 
extraction, followed by metabolite separation and detection, and data analysis. Steps: 573 
(1) describes the basic sample preparation and extraction in metabolomics studies 574 
across many applications; (2) analyte separation; metabolite separation on a column 575 
(chromatography) such as gas chromatography (GC), liquid chromatography (LC) or 576 
capillary electrophoresis (EC); (3) ionization: metabolites ionized at an ion source; (4) 577 
separated by a mass anlyzer as they fly or oscillate based on their m/z and (5)  578 
detected. Metabolites (from the chromatography) can be identified based on a 579 
combination of retention time (RT) and mass spectrometry (MS) signatures.    580 
 581 
Figure 2: Workflow for typical mass spectrometry–based metabolomics.   582 
 583 
 584 
Figure 3. Recovery test 585 
A mixture of extract of leaves, from Arabidopsis and Lettuce. Peaks were measured 586 
by GC-MS (a) and LC-MS (b) in leaves of Arabidopsis and lettuce, were used for 587 
recovery tests. The percentage recovery was estimated using the theoretical 588 
concentration of extracts mixture. Recovery test was carried out with Arabidopsis (A) 589 
and Lettuce (B) extracts (0.2 mg FW μl−1) of leaves. Extracts from “A” and “B” were 590 
mixed at 50:50 ratio [(A:B). The percentage recovery was estimated for evaluation 591 
using theoretical concentration of extracts mixture, [(level in leaves (A) × A%) + (level 592 
in leaves (B) × B%)]/100. Dashed lines indicate 70-130 % acceptance range. 593 
Compounds in gray are statistically outside this range. 594 
 595 
Figure 4. Workflow for metabolic data processes and downstream result 596 
documentation: 597 
Structure elucidation workflow of data acquisition, processing and annotation. Simple 598 
design for metabolic data documentation and how could be linked to mzTab49 tool to 599 
facilitate data representation, sharing and deposit to public repositories.  600 
 601 
 602 
Figure 5. Metabolite annotation and documentation : 603 
Structure elucidation workflow of metabolite identification. MS/MS fragmentation 604 
provides information about compound structure. Metabolite annotation; this can be 605 
achieved using reference compounds, MS
2
 analysis, nuclear magnetic resonance 606 
(NMR), photodiode array (PDA) detector for UV–VIS spectra detection will add support 607 
to metabolite annotation. In addition, database searching and molecular formula 608 
calculation.  609 
The Figure shows an example of the MS and  MS/MS spectra comparison of rutin (a 610 
flavonoid glycoside) revealed a 611 m/z peak in MS scan, and two major fragments of 611 
611 m/z in MS/MS fragments providing information about chemical moieties; loss of 612 
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rhamnose (-146 m/z) and glucose (162 m/z). The figure provides the 613 
recommendations for metabolic data to be included in a typical LC-MS experiment.  614 
 615 
 616 
Supplementary Figures 617 
Supplementary figure 1. Examples of mis-annotation  618 
Chromatograms and mass spectrum (M+H)
+
 ions of dipeptide Ser-Tyr (a) and tyrosine 619 
(b) measured by liquid chromatography-mass spectrometry (LC-MS) showing the mis-620 
annotation of metabolites. Both dipeptide Ser-Tyr and tyrosine  are present in the 621 
Arabidopsis samples and share identical retention time (RT=2.88). The 182.08 m/z 622 
fragment in source of Tyr-Lys shares elemental composition with tyrosine and thus can 623 
lead to erroneous annotation.  624 
Similarly, the dipeptide Tyr-Lys 310.17 m/z (c) and a small molecule defense 625 
compounds pipecolic acid 130.09 m/z (d) are both present in the Arabidopsis samples. 626 
Both compounds share identical retention time (RT1.05). One of the in source 627 
fragments of Tyr-Lys 130.09 m/z  shares elemental composition with pipecolic acid, 628 




Glossary  633 
APCI: atmospheric pressure chemical ionization (APCI) Chemical ionization of a 634 
sample that is a gas or nebulized liquid, using an atmospheric pressure corona 635 
discharge. 636 
API: atmospheric pressure ionization (API): Ionization process in which ions are 637 
formed from atoms or molecules at atmospheric pressure. 638 
 639 
EI: electron ionization (EI): also referred to as "electron impact" ionization technique 640 
that removes one or more electrons from an atom or molecule through interactions 641 
with electrons. 642 
ESI: electrospray ionization (ESI): ionization  process in which either cations or anions 643 
in solution are transferred to the gas phase via formation and desolvation at 644 
atmospheric pressure of a stream of highly charged droplets that result from applying 645 
a potential difference between the tip of the electrospray needle containing the solution 646 
and a counter electrode. 647 
GC-MS: gas chromatography–mass spectrometry (GC-MS) is a chromatographic 648 
analytical technique for detection of compounds with separation being performed in 649 
the gaseous phase. 650 
LC-MS: liquid chromatography–mass spectrometry (LC-MS) is a chromatographic 651 
analytical technique for detection of compounds, with separation being performed in 652 
the liquid phase. 653 
17 
 
m/z: Mass-to-charge ratio (m/z): a dimensionless quantity formed by dividing the ratio 654 
of the mass of an ion to the unified atomic mass unit, by its charge number.  655 
Matrix effects: (or ion suppression) phenomenon in mass spectrometry in which the 656 
ionization efficiency of a analyte is lowered by the presence of a different species.  657 
Typically the ionisation mechanism is suppressed, meaning that a lower response than 658 
expected is observed 659 
MS/MS: Acquisition of the spectra of the product ions or precursor ions of m/z selected 660 
ions, or of precursor ions of a selected neutral mass loss. 661 
Orbitrap: is an ion trap mass analyzer that traps ions in an orbital motion around the 662 
spindle. The image current from the trapped ions is detected and converted to a 663 
mass spectrum using the Fourier transform of the frequency signal. 664 
TOF: Time-of-Flight (TOF) a mass analyzer that separates ions of different m/z by 665 
their time of travel through a field-free vacuum region after having been given the same 666 
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